1996
DOI: 10.1128/mcb.16.7.3866
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of Functional Domain Organization in DNA Topoisomerase II from Humans and Saccharomyces cerevisiae

Abstract: The functional domain structure of human DNA topoisomerase II␣ and Saccharomyces cerevisiae DNA topoisomerase II was studied by investigating the abilities of insertion and deletion mutant enzymes to support mitotic growth and catalyze transitions in DNA topology in vitro. Alignment of the human topoisomerase II␣ and S. cerevisiae topoisomerase II sequences defined 13 conserved regions separated by less conserved or differently spaced sequences. The spatial tolerance of the spacer regions was addressed by inse… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

8
70
0

Year Published

1997
1997
2013
2013

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(78 citation statements)
references
References 67 publications
8
70
0
Order By: Relevance
“…Construction of Plasmids-The construction of pHT300 and pHT351i (pHT350-2) was described by Jensen et al (8). For the construction of the hexahistidine version of the human topoisomerase II␣ enzyme, see Bjergback et al (4).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Construction of Plasmids-The construction of pHT300 and pHT351i (pHT350-2) was described by Jensen et al (8). For the construction of the hexahistidine version of the human topoisomerase II␣ enzyme, see Bjergback et al (4).…”
Section: Methodsmentioning
confidence: 99%
“…To test the ability of 351i to complement the lack of endogenous topoisomerase II in BJ201, the LEU2-based construct pHT351i was transformed into BJ201 and cells were transferred to medium plates containing 5Ј-fluoro-orotic acid (1 mg/ml) to select against the URA3 plasmid carrying the Schizosaccharomyces pombe top2 ϩ gene (8). pHT300 was used as a positive control.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Plasmid pBY105 contains the yeast TPI promoter inserted into the polylinker region of the LEU2/ARS-CEN plasmid pRS315, which was used as the backbone for pHT212 and pHT⌬350 -407, carrying the wild-type human TOP2␣ cDNA and the human TOP2␣ cDNA with a deletion spanning amino acids 350 -407, respectively. Both pHT212 and pHT⌬350 -407 contain a bicomposite tag at the C-terminal end consisting of the c-Myc epitope and a hexahistidine tail (9). Modified versions of YEpWOB6 were used for overexpression of the hexahistidine-tagged human topoisomerase II␣ and h⌬350 -407 enzymes.…”
Section: Methodsmentioning
confidence: 99%
“…Topo IIA 3 enzymes share similar core domains and the corresponding catalytic "two-gate" mechanism: passing one segment of duplex DNA (the transfer or T-segment) through a transient double-stranded break in a second segment of DNA (the gate or G-segment) in an ATP-dependent process (5, 6, 8 -10). Catalytically dispensable C-terminal domains (CTDs) are structurally diverse among Topo IIA enzymes, but are important for cellular function as they contain phosphorylation sites and nuclear localization signals (11)(12)(13)(14)(15)(16). Growing evidence suggests that CTD variations among Topo IIA enzymes also alter the topological specificity and activity of the otherwise similar core domain functions of prokaryotic and eukaryotic Topo IIA enzymes (17)(18)(19)(20)(21)(22)(23).…”
mentioning
confidence: 99%